Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy of ligand-based targeting for the EGF system in cancer.
Yotsumoto F, Sanui A, Fukami T, Shirota K, Horiuchi S, Tsujioka H, Yoshizato T, Kuroki M, Miyamoto S. Yotsumoto F, et al. Among authors: sanui a. Anticancer Res. 2009 Nov;29(11):4879-85. Anticancer Res. 2009. PMID: 20032451 Free article. Review.
Serum Heparin-binding Epidermal Growth Factor-like Growth Factor (HB-EGF) as a Biomarker for Primary Ovarian Cancer.
Miyata K, Yotsumoto F, Fukagawa S, Kiyoshima C, Ouk NS, Urushiyama D, Ito T, Katsuda T, Kurakazu M, Araki R, Sanui A, Miyahara D, Murata M, Shirota K, Yagi H, Takono T, Kato K, Yaegashi N, Akazawa K, Kuroki M, Yasunaga S, Miyamoto S. Miyata K, et al. Among authors: sanui a. Anticancer Res. 2017 Jul;37(7):3955-3960. doi: 10.21873/anticanres.11779. Anticancer Res. 2017. PMID: 28668900
Association of Serum HB-EGF Value and Response to Chemotherapy in Patients with Recurrent Ovarian Cancer.
Izuchi D, Fukagawa S, Yotsumoto F, Shigekawa K, Yoshikawa K, Hirakawa T, Kiyoshima C, Ouk NS, Urushiyama D, Katsuda T, Miyata K, Ito T, Kurakazu M, Araki R, Sanui A, Miyahara D, Murata M, Ito H, Shirota K, Kuroki M, Yasunaga S, Miyamoto S. Izuchi D, et al. Among authors: sanui a. Anticancer Res. 2018 Jul;38(7):4347-4351. doi: 10.21873/anticanres.12735. Anticancer Res. 2018. PMID: 29970572
BK-UM in patients with recurrent ovarian cancer or peritoneal cancer: a first-in-human phase-I study.
Miyamoto S, Yotsumoto F, Ueda T, Fukami T, Sanui A, Miyata K, Nam SO, Fukagawa S, Katsuta T, Maehara M, Kondo H, Miyahara D, Shirota K, Yoshizato T, Kuroki M, Nishikawa H, Saku K, Tsuboi Y, Ishitsuka K, Takamatsu Y, Tamura K, Matsunaga A, Hachisuga T, Nishino S, Odawara T, Maeda K, Manabe S, Ishikawa T, Okuno Y, Ohishi M, Hikita T, Mizushima H, Iwamoto R, Mekada E. Miyamoto S, et al. Among authors: sanui a. BMC Cancer. 2017 Jan 31;17(1):89. doi: 10.1186/s12885-017-3071-5. BMC Cancer. 2017. PMID: 28143428 Free PMC article. Clinical Trial.
17 results